Inhibitory effects of etodolac, a selective COX-2 inhibitor, on the occurrence of tumors in colitis-induced tumorigenesis model in rats.
Takeda J, Kitajima K, Fujii S, Horiuchi H, Hori H, Chibana Y, Okuyama T, Tominaga K, Ichikawa K, Ono Y, Teramoto T, Ohkura Y, Imura J, Shinoda M, Chiba T, Sakamoto C, Kawamata H, Fujimori T.
Takeda J, et al. Among authors: horiuchi h.
Oncol Rep. 2004 May;11(5):981-5.
Oncol Rep. 2004.
PMID: 15069535